Lantheus Holdings, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Lantheus Holdings, Inc. stock issued during period, value, stock options exercised for the quarter ending 2016-12-31 was $170.00K.
- Lantheus Holdings, Inc. stock issued during period, value, stock options exercised for fiscal 2017 was $3.43M, a 1386.58% increase from fiscal 2016.
- Lantheus Holdings, Inc. stock issued during period, value, stock options exercised for fiscal 2016 was $231.00K.
- Lantheus Holdings, Inc. stock issued during period, value, stock options exercised for fiscal 2014 was $13.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2017-12-31 | $3.43M 10-K · filed 2019-02-20 | |
| 2016-12-31 | $170.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $231.00K 10-K · filed 2018-02-26 |
| 2014-12-31 | $13.00K 10-K · filed 2017-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |